ニュース
Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
There have been 181 cases of acute/chronic pancreatitis and five deaths linked to Mounjaro, while Ozempic and Wegovy have one death and 113 pancreatitis reports attached to them (via Sky News).
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
Weight loss drug Wegovy, which also goes by the name Ozempic, is responsible for slimming down celebrities such as Oprah ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
Wegovy, the ₹26K/month weight-loss jab, hits India with bold promises—from fat loss to heart health. But is this pharma fix a ...
While the makers of Ozempic have stated that its GLP-1 medication was not made to be used as a weight loss drug, nor should ...
Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...
With the launch of Wegovy by Danish pharmaceutical giant Novo Nordisk and US major Eli Lilly’s Mounjaro already in ...
Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する